Necrosis and apoptosis

40,076views

Necrosis and apoptosis

Watch later

Watch later

Nernst equation
Cytoskeleton and intracellular motility
Cell signaling pathways
Resting membrane potential
Gene regulation
Epigenetics
Nuclear structure
DNA structure
Transcription of DNA
Amino acids and protein folding
Necrosis and apoptosis
Endometrial hyperplasia and cancer: Clinical
Lung cancer and mesothelioma: Pathology review
Metaplasia and dysplasia
Oral cancer
Testicular cancer
Lung cancer
Asthma
Atrial septal defect
Apnea, hypoventilation and pulmonary hypertension: Pathology review
Acute respiratory distress syndrome
Angina pectoris
Aortic valve disease
Bronchiectasis
Chronic bronchitis
Chronic venous insufficiency
Coarctation of the aorta
Deep vein thrombosis
Emphysema
Endocarditis
Gas exchange in the lungs, blood and tissues
Heart failure
Mitral valve disease
Cor pulmonale
Heart failure: Pathology review
Myocarditis
Diabetes mellitus: Pathology review
Adrenocorticotropic hormone
Chlamydia trachomatis
Cortisol
Abnormal uterine bleeding: Clinical
Cushing syndrome
Endometriosis
Glucagon
Glucocorticoids
Herpes simplex virus
HIV (AIDS)
Hypothyroidism: Pathology review
Hypothyroidism
Insulin
Neisseria gonorrhoeae
Pelvic inflammatory disease
Polycystic ovary syndrome
Benign prostatic hyperplasia
Thyroid hormones
Testosterone
Syndrome of inappropriate antidiuretic hormone secretion (SIADH)
Primary adrenal insufficiency
Hyperthyroidism: Pathology review
Chronic leukemia
Anemia of chronic disease
Hemophilia
Heparin-induced thrombocytopenia
Hypocalcemia
Hypermagnesemia
Hypokalemia
Hypomagnesemia
Inflammation
Innate immune system
Complement system
Iron deficiency anemia
Leukemias: Pathology review
Platelet disorders: Pathology review
Sickle cell disease (NORD)
Type IV hypersensitivity
Vaccinations
Acute pyelonephritis
Celiac disease
Cirrhosis
Congenital disorders: Clinical
Appendicitis
Autoimmune hepatitis
Bowel obstruction
Chronic cholecystitis
Chronic pyelonephritis
Crohn disease
Gastroesophageal reflux disease (GERD)
Nephrotic syndromes: Pathology review
Irritable bowel syndrome
Lower urinary tract infection
Biliary colic
Peptic ulcer
Renal failure: Pathology review
Urinary tract infections: Pathology review
Viral hepatitis
Pancreatitis: Pathology review
Alcohol-associated liver disease
Ulcerative colitis
Medullary cystic kidney disease
Small bowel ischemia and infarction
Chronic kidney disease
Acute cholecystitis
Skin cancer
Autosomal trisomies: Pathology review
Selective permeability of the cell membrane
Free radicals and cellular injury
Pericarditis and pericardial effusion
Peripheral artery disease
Cauda equina syndrome
Cranial nerves
Dementia: Pathology review
Arteriovenous malformation
Bipolar and related disorders
Seizures and epilepsy
Generalized anxiety disorder
Headaches: Pathology review
Huntington disease
Ischemic stroke
Major depressive disorder
Meningitis
Migraine
Multiple sclerosis
Myasthenia gravis
Panic disorder
Parkinson disease
Alzheimer disease
Approach to abnormal uterine bleeding in reproductive-aged patients: Clinical sciences
Coagulation disorders: Pathology review
Factor V Leiden
Hodgkin lymphoma
Disseminated intravascular coagulation
Non-Hodgkin lymphoma
Introduction to the immune system
Acute pancreatitis
Approach to congenital heart diseases (acyanotic): Clinical sciences
Acne vulgaris
Atopic dermatitis
Back pain: Pathology review
Bone disorders: Pathology review
Burns
Osteoarthritis
Osteoporosis
Paget disease of bone
Psoriasis
Rheumatoid arthritis
Varicella zoster virus
Introduction to pharmacology
Drug administration and dosing regimens
Enzyme function
Pharmacokinetics: Drug metabolism
Pharmacokinetics: Drug elimination and clearance
Pharmacokinetics: Drug absorption and distribution
Pharmacodynamics: Drug-receptor interactions
Pharmacodynamics: Desensitization and tolerance
Pharmacodynamics: Agonist, partial agonist and antagonist
Opioid agonists, mixed agonist-antagonists and partial agonists
Opioid use disorder
Acetaminophen (Paracetamol)
Non-steroidal anti-inflammatory drugs
Opioid antagonists
Anticoagulants: Direct factor inhibitors
Anticoagulants: Heparin
Anticoagulants: Warfarin
Antiplatelet medications
Thrombolytics
Hematopoietic medications
Role of Vitamin K in coagulation
Loop diuretics
Miscellaneous lipid-lowering medications
Potassium sparing diuretics
Adrenergic antagonists: Alpha blockers
Calcium channel blockers
Adrenergic antagonists: Beta blockers
Lipid-lowering medications: Statins
Lipid-lowering medications: Fibrates
Class II antiarrhythmics: Beta blockers
Class IV antiarrhythmics: Calcium channel blockers and others
Class I antiarrhythmics: Sodium channel blockers
Thiazide and thiazide-like diuretics
ACE inhibitors, ARBs and direct renin inhibitors
Positive inotropic medications
Anti-mite and louse medications
Antimalarials
Hepatitis medications
Anthelmintic medications
Integrase and entry inhibitors
Antimetabolites: Sulfonamides and trimethoprim
Azoles
Cell wall synthesis inhibitors: Cephalosporins
Cell wall synthesis inhibitors: Penicillins
DNA synthesis inhibitors: Metronidazole
DNA synthesis inhibitors: Fluoroquinolones
Echinocandins
Herpesvirus medications
Mechanisms of antibiotic resistance
Miscellaneous cell wall synthesis inhibitors
Miscellaneous protein synthesis inhibitors
Neuraminidase inhibitors
Non-nucleoside reverse transcriptase inhibitors (NNRTIs)
Nucleoside reverse transcriptase inhibitors (NRTIs)
Protease inhibitors
Protein synthesis inhibitors: Aminoglycosides
Protein synthesis inhibitors: Tetracyclines
Antihistamines for allergies
Miscellaneous antifungal medications
Antituberculosis medications
Androgens and antiandrogens
Aromatase inhibitors
Estrogens and antiestrogens
PDE5 inhibitors
Progestins and antiprogestins
Uterine stimulants and relaxants
Acid reducing medications
Antidiarrheals
Laxatives and cathartics
Non-corticosteroid immunosuppressants and immunotherapies
Hyperthyroidism medications
Hypoglycemics: Insulin secretagogues
Hypothyroidism medications
Insulins
Miscellaneous hypoglycemics
Mineralocorticoids and mineralocorticoid antagonists
Sympatholytics: Alpha-2 agonists
Anticonvulsants and anxiolytics: Barbiturates
Anticonvulsants and anxiolytics: Benzodiazepines
Nonbenzodiazepine anticonvulsants
Atypical antipsychotics
Atypical antidepressants
Typical antipsychotics
Lithium
Monoamine oxidase inhibitors
Selective serotonin reuptake inhibitors
Serotonin and norepinephrine reuptake inhibitors
Anti-parkinson medications
Tricyclic antidepressants
Cholinomimetics: Direct agonists
Cholinomimetics: Indirect agonists (anticholinesterases)
Muscarinic antagonists
Migraine medications
Bronchodilators: Beta 2-agonists and muscarinic antagonists
Bronchodilators: Leukotriene antagonists and methylxanthines
Antigout medications
Folate (Vitamin B9) deficiency
Vitamin D
Fat-soluble vitamin deficiency and toxicity: Pathology review
Approach to viral exanthems (pediatrics): Clinical sciences
Mumps virus
Measles virus
Rubella virus
Bordetella pertussis (Whooping cough)
Poliovirus

Transcript

Watch video only

Generally speaking, cells have two ways to die. One way is by apoptosis, which is a form of programmed cell death. The second way is by necrosis, which is when cells die due to injury or disease. Overall, apoptosis occurs much more often than necrosis. One example is when old skin cells undergo apoptosis and get replaced by new skin cells. Another example is in our hands and feet during fetal development. Initially, human hands and feet look like duck’s feet, with webs of skin connecting the fingers. But the cells in the webbing undergo apoptosis, and that allows us to form individual digits that allow us to pick our nose and play the piano. In contrast, necrosis occurs less frequently. An example of necrosis is when a blood vessel that feeds an area of the body, say the big toe, becomes blocked and can’t deliver oxygen and nutrients to the cells like usual, it causes ischemia, and the cells die. As a result, the tissues of the toe will turn a nasty shade of black, signaling necrosis.

In apoptosis, there are two activating mechanisms - the intrinsic pathway, also called the mitochondrial pathway, and the extrinsic pathway, also called the death receptor pathway.

The intrinsic pathway occurs when a cell is exposed to stress like radiation, hypoxia, or low oxygen, a high intracellular concentration of calcium ions, or oxidative stress, which is where reactive molecules with unpaired electrons called free radicals steal electrons from nearby molecules.

These stressors cause two intracellular proteins, Bax and Bak, to move from the cytosol to the mitochondria. Once in the mitochondria, Bax and Bak pierce the outer mitochondrial membrane making it porous and leaky. This allows two additional proteins, called SMACS and cytochrome C, to spill into the cytosol. SMACS binds to proteins that normally inhibit apoptosis and deactivates them. Meanwhile, cytochrome C binds to both ATP - the main form of intracellular energy - as well as an enzyme called Apaf-1. Together, cytochrome C and Apaf-1 combine to form a large protein complex called an apoptosome.

The Apaf-1 portion of the apoptosome then cleaves an enzyme called pro-caspase 9 into its active form, caspase-9. Caspase 9 then goes on to activate caspase-3, and caspase-3 goes on to activate other caspases - like a chain event. Eventually, this caspase cascade leads a cell to commit apoptosis.

That’s because these caspases cleave the proteins that make up the cell’s nucleus, organelles, and cytoskeleton - a bit like a ninja sabotaging a bridge by removing its nuts and bolts.

This destroys the cytoskeleton, as well as the proteins that anchor the cytoskeleton to the cell membrane. As a result, the cell membrane starts to develop blebs - or bulges in the cell membrane. The blebs are structurally weak, so they start to break off from the cell membrane, eventually forming small apoptotic bodies that are eaten by neighboring phagocytes. At the same time, the apoptotic cell releases anti-inflammatory signals, thereby preventing the recruitment of other immune cells from the blood and preventing tissue inflammation. So apoptosis is a neat process that conveniently recycles the organic contents of the dead cell.

Now, when the signals from apoptosis come from outside the cell - it’s called the extrinsic pathway. One example is when a nearby macrophage recognizes an old cell, a pathogenic cell, or a cell that has completed its task. In these situations, a macrophage can initiate apoptosis by releasing tumor necrosis factor alpha or TNF-alpha, a cell-signaling protein,

that binds to very appropriately named death receptors on the target cell membrane, one example being tumor necrosis factor receptor 1. The cytosolic end of this receptor, dives deep inside the cell, and it’s called the death domain. When the TNF-alpha binds to the tumor necrosis factor receptor 1, the death domain changes its shape and is able to bind to two proteins. One is called Fas-associated protein with death domain or FADD and the other is called take a deep breath here

Tumor necrosis factor receptor type 1-associated DEATH domain protein or TRADD.

So the death receptor, FADD, and TRADD come together to form a multi-complex protein called... wait for it... the death-inducing signaling complex or DISC. Once everything is together, DISC cleaves pro-caspase-8 into caspase-8, which in turn activates caspase-3, and caspase-3 goes on to activate other caspases. This initiates the caspase cascade that commits the cell to apoptosis. After that, the process of apoptosis unfolds just like in the intrinsic pathway.

Now in addition to macrophages, if a cytotoxic T cell detects that a cell is expressing foreign antigens, the T cell will express a protein on its membrane called Fas ligand which binds to a death receptor on the target cell called the first apoptosis signal receptor - or Fas receptor. Similar to the death domain of tumor necrosis factor receptor 1, the Fas receptor protein also has its very own death domain that can bind to FADD to form DISC. As before, DISC activates pro-caspase-8 into caspase-8 and that triggers the caspase cascade which leads to apoptosis.

Alright, let’s switch gears and take a look at necrosis, which can be triggered by external factors like an infection, or extremely hot or cold temperatures; as well as internal factors like tissue ischemia. Now, there are three main types of necrosis called primary, secondary, and regulated necrosis.

Primary necrosis, also known as accidental necrosis or oncotic necrosis, typically occurs when ischemia disrupts the normal functioning of mitochondria. As a result, the cell is unable to synthesize ATP, causing all ATP-dependent cellular processes to stop working, including the ionic pumps that regulate the flow of ions in and out of the cell. Without functioning ion pumps, sodium starts to flow into the cell, and it's followed by water.

This causes the cell to swell up like a balloon. This process of cell swelling is called oncosis. Soon, the cell bursts and spills its internal contents and small molecules called damage-associated molecular patterns into the surroundings.

These molecules trigger the inflammatory response and attract nearby immune cells to release substances like proteases, which are enzymes that degrade proteins, and reactive oxygen species, which are unstable molecules that can damage other cells. If this inflammatory process occurs among enough cells, it can destroy the tissue, and if it happens on a massive level it can lead to organ dysfunction. Now it turns out that primary necrosis comes in a few different flavors.

First, there’s coagulative necrosis, which occurs when a tissue becomes hypoxic - has low levels of oxygen - most commonly due to ischemia.

Key Takeaways

Necrosis is a type of cell death that occurs when cells are damaged by external factors like an infection, as well as internal factors like tissue ischemia. There are six types of necrosis: coagulative and gangrenous necrosis, which happen to hypoxic tissues; liquefactive necrosis, which happens because of hydrolytic enzymes; caseous necrosis - like in tuberculosis; fat necrosis, which happens when fatty acids spill outside adipose cells, like during trauma, and finally fibrinoid necrosis - which is caused by fibrin deposits, like in malignant hypertension.

Apoptosis, on the other hand, is a programmed cell death that occurs when the body needs to get rid of damaged or unnecessary cells. Apoptosis occurs due to intrinsic and extrinsic pathways. With apoptosis, white blood cells come in and clean up the dead tissue, so this is a neat way for cells to die.

Sources

    1. FRCPath, K. V. M. M., Mbbs, A. A. K., & Md, J. A. C., PhD. (2020). Robbins & Cotran Pathologic Basis of Disease (Robbins Pathology) (10th ed.). Elsevier. ISBN 9780323531139 

    1. Hammer, G., & McPhee, S. (2018). Pathophysiology of Disease: An Introduction to Clinical Medicine 8E (8th ed.). McGraw Hill / Medical. ISBN 978-1260026504 

    1. Jameson, L. J., Fauci, A., Kasper, D., Hauser, S., Longo, D., & Loscalzo, J. (2018). Harrison’s Principles of Internal Medicine, Twentieth Edition (Vol.1 & Vol.2) (20th ed.). McGraw Hill / Medical. ISBN 978-1264268504 

    1. Park, M. Y., Ha, S. E., Vetrivel, P., Kim, H. H., Bhosale, P. B., Abusaliya, A., & Kim, G. S. (2021). Differences of Key Proteins between Apoptosis and Necroptosis. BioMed research international, 2021, 3420168. https://doi.org/10.1155/2021/3420168 

    1. Del Re, D. P., Amgalan, D., Linkermann, A., Liu, Q., & Kitsis, R. N. (2019). Fundamental Mechanisms of Regulated Cell Death and Implications for Heart Disease. Physiological reviews, 99(4), 1765–1817. https://doi.org/10.1152/physrev.00022.2018